The Keosys Blog

Keosys Jun 8, 2022

Focus On Selective Internal Radiation Therapy with HCC

This is an excerpt from our free eBook, “Hepatocellular Carcinoma and Imaging..

Keosys May 17, 2022

Evaluating Tumor Response in HCC

This is an excerpt from our free eBook, “Hepatocellular Carcinoma and Imaging..

Keosys Mar 28, 2022

Interview: An Interventional Radiologist Talks About Radioembolization in the Treatment of HCC Today

Dr. Yan Rolland, head of the diagnosis and interventional radiology department..

Keosys Mar 15, 2022

Interview: A Radiology Professor Talks About mRECIST, Reading Images in Clinical Trials, and More

Maxime Ronot, Professor at the Université de Paris, and Radiologist in the..

Keosys Feb 23, 2022

Interview: Keosys Advances into a Promising New Year

With our 20th anniversary year recently completed and a new year underway, we..

Keosys Oct 22, 2021

How to Prepare an Imaging Study While Minimizing Budget and Risk

Sometimes sponsors and CROs are not sure in the early stages of a trial that..

Keosys Sep 9, 2021

Interview: A Medical Doctor Finds Her Biotech Home

We recently spoke with Eveline Boucher, MD, Senior Medical Director for Boston..

Keosys Jul 20, 2021

Keo-Tales: Introducing the Keosys Interns

Every year, Keosys takes on a select number of interns, giving them the..

Keosys Jul 13, 2021

Central Review According to iRECIST in Cancer Immunotherapy Clinical Trials

This is an excerpt from our free eBook “Imaging and Read Criteria in Cancer..

Keosys Jun 24, 2021

iRECIST and Tumor Response to Immunotherapy with Infographic

iRecist and Tumor Response to Immunotherapy When immunotherapy is used to..

Keosys Jun 23, 2021

Keo-Tales: Looking Back and Looking Forward

Keosys is an imaging solutions provider supporting biopharmaceutical companies..

Keosys Jun 15, 2021

Read Criteria and the Evaluation of Antitumor Responses With Immunotherapeutic Agents